An interventional study of Education (ALS provider course) in Egypt in Chestcompressionadequacy, sponsored by National Hepatology & Tropical Medicine Research Institute. Recruiting at 2 sites in Egypt. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-25.
Sponsored by National Hepatology & Tropical Medicine Research Institute · Not applicable, Interventional, and Other
to assess chest compression competency in healthcare providers following ALS training to identify areas for improvement and ensure high-quality CPR delivery.
Assessment of certain CPR metrics will be done by the following approach;
Pre-course assessment:
Baseline measurement of CPR skills for two minutes cycle using a validated simulator by specialized adult feedback manikins e.g. Prestan CPR Feedback Manikins (i.e. built-in indicators for compression rate and depth), the following metrics will be followed and recorded:
Chest Compression Metrics:
A. Compression Depth: at least 2 inches (5 cm) for adults, with a maximum of 2.4 inches (6 cm)3.
B. Compression Rate: 100 to 120 compressions per minute3. C. Release (Recoil): Full chest recoil is essential to allow for effective venous return3.
D. Hands-off time (Pause): Measured during the simulation, less than 10 seconds3.
E. Chest Compression Fraction (CCF): Calculated as the ratio of the time spent performing compressions to the total time spent on CPR (including compressions, ventilations, and any pauses). Target will be ≥80%4.
F. Compression Quality: An overall assessment (percentage shown by the feedback device) of the effectiveness of compressions, which may include depth, rate, and continuity.
A. Tidal Volume: Target will be 400-700 mL of air for visible chest rise (in adults)3.
B. Ventilation Rate: 1 breath every 6 seconds (10 breaths per minute during continuous chest compressions for adults)3.
Intervention:
Participants complete an ALS course, including theoretical and practical components focused on scenario based simulations for CPR and chest compressions.
Post-course assessment:
Immediate assessment at the end of the second day for CPR competency of 2 minutes cycle using the same simulator and the same parameters assessed pre-course.The scoring method is designed so that each item in the checklist is awarded zero or one point, with zero indicating lack of skill and one is indicating proficiency in the relevant area. Thus, participants' skills levels are determined and categorized.
National Hepatology & Tropical Medicine Research Institute is the lead sponsor of 20 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
assessment of participants prior to initiation of ALS course
Other: Education (ALS provider course) in Egypt
Participants complete an ALS course, including theoretical and practical components focused on scenario based simulations for CPR and chest compressions.
The primary outcome is to assess CPR competency between ALS providers at the end of the ALS course if they will achieve the standard cutoff values and score.
CCF%
Time frame: two day course
The primary outcome is to assess CPR competency between ALS providers at the end of the ALS course if they will achieve the standard cutoff values and score.
Chest compression depth %
Time frame: Two day course
Plan to share: Undecided — results after acceptance for publication
No publications or documents are linked to this record.
Started Jun 2025 (actual). Primary completion is estimated for Mar 2026, 9 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Hepatology & Tropical Medicine Research Institute